All lobbying filings

HIV AND HEPATITIS POLICY INSTITUTE

Lobbying for HIV AND HEPATITIS POLICY INSTITUTE · Patient advocacy

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $10,000.00 expenses · posted Oct 17, 2025

Official filing document

Bills named in this filing 2

HR 5126
HIV Prevention Now Act
HR 5127
PrEP and PEP are Prevention Act

Lobbying activity 4

Budget/Appropriations

CDC domestic HIV and hepatitis prevention, Ryan White Comprehensive AIDS Resources Emergency (CARE) Act programs, Ending the HIV Epidemic Initiative, including PrEP activities for community health centers, Minority AIDS Initiative, and NIH AIDS research

Health Issues

HIV Prevention Now Act (HR 5126); PrEP & PEP are Prevention Act (HR 5127); National PrEP Program

Insurance

Preventive Service insurance coverage for PrEP, Copay Assistance & Cost sharing for prescription drugs, Essential Health Benefits & Prescription Drugs

Pharmacy

Preventive Service coverage for PrEP, Copay Assistance & Cost sharing for prescription drugs; Essential Health Benefits & Prescription Drugs

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.